Author:
Zheng Xiaoyun,Huang Xiaobo,Luo Jianmin,Li Juan,Li Wei,Liu Qifa,Niu Ting,Wang Xiaodong,Zhou Jianfeng,Zhang Xi,Hu Jianda,Liu Kaiyan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference22 articles.
1. de la Torre P, Reboli AC. Micafungin: an evidence-based review of its place in therapy. Core Evid. 2014;9:27–39.
2. Drgona L, Khachatryan A, Stephens J, et al. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis. 2014;33:7–21.
3. Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection. 2008;36:296–313.
4. Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol. 2011;3:175–91.
5. Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: review of literature. Chin Med J (Engl). 2013;126:361–8.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献